Literature DB >> 19357

Classical and alternative complement pathway activation by pneumococci.

C G Stephens, R C Williams, W P Reed.   

Abstract

Sixty-two strains of Streptococcus pneumoniae were studied for their abilities to consume selected components of classical and alternative complement pathways in human sera. The classical pathway was blocked by chelating calcium with ethyleneglycol-bios (beta-aminoethyl ether)-N,N-tetraacetic acid and by removing C4. The alternative pathway was blocked by removing factor B. Each strain's activation of the two pathways was compared with its nonimmune reactivity with the Fc region of immunoglobulin G (IgG). Activation of the classical complement pathway appeared to be independent of such Fc reactivity. Highly Fc-reactive strains, however, were shown to activate the alternative pathway more effectively than did less Fc-reactive strains. Since pneumococcal activation of the alternative pathway requires non-immunospecific IgG, these findings suggest that nonimmune binding of IgG on the pneumococcal surface endows it with complement-activating properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19357      PMCID: PMC421118          DOI: 10.1128/iai.17.2.296-302.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Investigations of the complement-fixing sites of immunoglobulins.

Authors:  B J Johnson; K E Thames
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus.

Authors:  R Austrian
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Antigenemia in fulminant pneumococcemia.

Authors:  J D Coonrod; R P Leach
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

4.  Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.

Authors:  J A Winkelstein; H S Shin; W B Wood
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

5.  Possible pathogenetic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC).

Authors:  M W Rytel; T H Dee; J E Ferstenfeld; G T Hensley
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

6.  Reactions between certain strains of pneumococci and Fc of IgG.

Authors:  C G Stephens; W P Reed; G Kronvall; R C Williams
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

7.  The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.

Authors:  J A Winkelstein; H S Shin
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

8.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

9.  Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.

Authors:  R G Medicus; O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  19 in total

1.  Complement activity in middle ear effusions.

Authors:  J M Bernstein; H A Schenkein; R J Genco; W R Bartholomew
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

2.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

4.  Interaction of pneumococcal antigens with complement in rats.

Authors:  J D Coonrod; S Jenkins
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

5.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Authors:  T Kelly; J P Dillard; J Yother
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Opsonization of various capsular (K) E. coli by the alternative complement pathway.

Authors:  P Stevens; L S Young; S Adamu
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

7.  Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.

Authors:  A J Williams; M J Hastings; C S Easmon; P J Cole
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

8.  Complement activation by Coccidioides immitis: in vitro and clinical studies.

Authors:  J N Galgiani; P Yam; L D Petz; P L Williams; D A Stevens
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits.

Authors:  S E Goldblum; W P Reed; L L Barton
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

10.  Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.

Authors:  S E Goldblum; W P Reed
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.